Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
University of Leeds
Enrollment target
~400 participants
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated September 2024